Copyright Reports & Markets. All rights reserved.

Global Apoptosis Assays Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Apoptosis Assays Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Caspase Assays
      • 1.4.3 Annexin V and Cell Permeability Assays
      • 1.4.4 DNA Fragmentation Assays
      • 1.4.5 Mitochondrial Assays
    • 1.5 Market by Application
      • 1.5.1 Global Apoptosis Assays Market Share by Application (2014-2025)
      • 1.5.2 Drug Discovery & Development
      • 1.5.3 Clinical & Diagnostic Applications
      • 1.5.4 Basic Research
      • 1.5.5 Stem Cell Research
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Apoptosis Assays Market Size
    • 2.2 Apoptosis Assays Growth Trends by Regions
      • 2.2.1 Apoptosis Assays Market Size by Regions (2014-2025)
      • 2.2.2 Apoptosis Assays Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Apoptosis Assays Market Size by Manufacturers
      • 3.1.1 Global Apoptosis Assays Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Apoptosis Assays Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Apoptosis Assays Market Concentration Ratio (CR5 and HHI)
    • 3.2 Apoptosis Assays Key Players Head office and Area Served
    • 3.3 Key Players Apoptosis Assays Product/Solution/Service
    • 3.4 Date of Enter into Apoptosis Assays Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Apoptosis Assays Market Size by Type (2014-2019)
    • 4.2 Global Apoptosis Assays Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Apoptosis Assays Market Size (2014-2019)
    • 5.2 Apoptosis Assays Key Players in United States
    • 5.3 United States Apoptosis Assays Market Size by Type
    • 5.4 United States Apoptosis Assays Market Size by Application

    6 Europe

    • 6.1 Europe Apoptosis Assays Market Size (2014-2019)
    • 6.2 Apoptosis Assays Key Players in Europe
    • 6.3 Europe Apoptosis Assays Market Size by Type
    • 6.4 Europe Apoptosis Assays Market Size by Application

    7 China

    • 7.1 China Apoptosis Assays Market Size (2014-2019)
    • 7.2 Apoptosis Assays Key Players in China
    • 7.3 China Apoptosis Assays Market Size by Type
    • 7.4 China Apoptosis Assays Market Size by Application

    8 Japan

    • 8.1 Japan Apoptosis Assays Market Size (2014-2019)
    • 8.2 Apoptosis Assays Key Players in Japan
    • 8.3 Japan Apoptosis Assays Market Size by Type
    • 8.4 Japan Apoptosis Assays Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Apoptosis Assays Market Size (2014-2019)
    • 9.2 Apoptosis Assays Key Players in Southeast Asia
    • 9.3 Southeast Asia Apoptosis Assays Market Size by Type
    • 9.4 Southeast Asia Apoptosis Assays Market Size by Application

    10 India

    • 10.1 India Apoptosis Assays Market Size (2014-2019)
    • 10.2 Apoptosis Assays Key Players in India
    • 10.3 India Apoptosis Assays Market Size by Type
    • 10.4 India Apoptosis Assays Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Apoptosis Assays Market Size (2014-2019)
    • 11.2 Apoptosis Assays Key Players in Central & South America
    • 11.3 Central & South America Apoptosis Assays Market Size by Type
    • 11.4 Central & South America Apoptosis Assays Market Size by Application

    12 International Players Profiles

    • 12.1 Merck
      • 12.1.1 Merck Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Apoptosis Assays Introduction
      • 12.1.4 Merck Revenue in Apoptosis Assays Business (2014-2019)
      • 12.1.5 Merck Recent Development
    • 12.2 Thermo Fisher Scientific
      • 12.2.1 Thermo Fisher Scientific Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Apoptosis Assays Introduction
      • 12.2.4 Thermo Fisher Scientific Revenue in Apoptosis Assays Business (2014-2019)
      • 12.2.5 Thermo Fisher Scientific Recent Development
    • 12.3 Becton Dickinson
      • 12.3.1 Becton Dickinson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Apoptosis Assays Introduction
      • 12.3.4 Becton Dickinson Revenue in Apoptosis Assays Business (2014-2019)
      • 12.3.5 Becton Dickinson Recent Development
    • 12.4 Bio-Rad Laboratories
      • 12.4.1 Bio-Rad Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Apoptosis Assays Introduction
      • 12.4.4 Bio-Rad Laboratories Revenue in Apoptosis Assays Business (2014-2019)
      • 12.4.5 Bio-Rad Laboratories Recent Development
    • 12.5 Promega Corporation
      • 12.5.1 Promega Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Apoptosis Assays Introduction
      • 12.5.4 Promega Corporation Revenue in Apoptosis Assays Business (2014-2019)
      • 12.5.5 Promega Corporation Recent Development
    • 12.6 Abcam
      • 12.6.1 Abcam Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Apoptosis Assays Introduction
      • 12.6.4 Abcam Revenue in Apoptosis Assays Business (2014-2019)
      • 12.6.5 Abcam Recent Development
    • 12.7 Bio-Techne
      • 12.7.1 Bio-Techne Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Apoptosis Assays Introduction
      • 12.7.4 Bio-Techne Revenue in Apoptosis Assays Business (2014-2019)
      • 12.7.5 Bio-Techne Recent Development
    • 12.8 Sartorius
      • 12.8.1 Sartorius Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Apoptosis Assays Introduction
      • 12.8.4 Sartorius Revenue in Apoptosis Assays Business (2014-2019)
      • 12.8.5 Sartorius Recent Development
    • 12.9 Biotium
      • 12.9.1 Biotium Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Apoptosis Assays Introduction
      • 12.9.4 Biotium Revenue in Apoptosis Assays Business (2014-2019)
      • 12.9.5 Biotium Recent Development
    • 12.10 Creative Bioarray
      • 12.10.1 Creative Bioarray Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Apoptosis Assays Introduction
      • 12.10.4 Creative Bioarray Revenue in Apoptosis Assays Business (2014-2019)
      • 12.10.5 Creative Bioarray Recent Development
    • 12.11 Geno Technology
    • 12.12 GeneCopoeia
    • 12.13 Danaher
    • 12.14 GE Healthcare
    • 12.15 PerkinElmer

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Apoptosis (programmed cell death) is the genetically controlled ablation of cells during normal development. Apoptosis is distinct from necrosis in both the biochemical and the morphological changes that occur. In contrast to necrotic cells, apoptotic cells are characterized morphologically by compaction of the nuclear chromatin, shrinkage of the cytoplasm and production of membrane-bound apoptotic bodies.
      In 2018, the global Apoptosis Assays market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Apoptosis Assays status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Apoptosis Assays development in United States, Europe and China.

      The key players covered in this study
      Merck
      Thermo Fisher Scientific
      Becton Dickinson
      Bio-Rad Laboratories
      Promega Corporation
      Abcam
      Bio-Techne
      Sartorius
      Biotium
      Creative Bioarray
      Geno Technology
      GeneCopoeia
      Danaher
      GE Healthcare
      PerkinElmer

      Market segment by Type, the product can be split into
      Caspase Assays
      Annexin V and Cell Permeability Assays
      DNA Fragmentation Assays
      Mitochondrial Assays

      Market segment by Application, split into
      Drug Discovery & Development
      Clinical & Diagnostic Applications
      Basic Research
      Stem Cell Research

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Apoptosis Assays status, future forecast, growth opportunity, key market and key players.
      To present the Apoptosis Assays development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Apoptosis Assays are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now